<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Foskolou IP</submitter><funding>Fundação para a Ciência e a Tecnologia</funding><funding>Allos Therapeutics</funding><funding>Karolinska Institutet</funding><funding>Wellcome Trust</funding><pagination>113013</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7618115</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>42(9)</volume><pubmed_abstract>2-Hydroxyglutarate (2HG) is a byproduct of the tricarboxylic acid (TCA) cycle and is readily detected in the tissues of healthy individuals. 2HG is found in two enantiomeric forms: S-2HG and R-2HG. Here, we investigate the differential roles of these two enantiomers in cluster of differentiation (CD)8&lt;sup>+&lt;/sup> T cell biology, where we find they have highly divergent effects on proliferation, differentiation, and T cell function. We show here an analysis of structural determinants that likely underlie these differential effects on specific α-ketoglutarate (αKG)-dependent enzymes. Treatment of CD8&lt;sup>+&lt;/sup> T cells with exogenous S-2HG, but not R-2HG, increased CD8&lt;sup>+&lt;/sup> T cell fitness in vivo and enhanced anti-tumor activity. These data show that S-2HG and R-2HG should be considered as two distinct and important actors in the regulation of T cell function.</pubmed_abstract><journal>Cell reports</journal><pubmed_title>The two enantiomers of 2-hydroxyglutarate differentially regulate cytotoxic T cell function.</pubmed_title><pmcid>PMC7618115</pmcid><funding_grant_id>092738</funding_grant_id><funding_grant_id>214283/Z/18/Z</funding_grant_id><funding_grant_id>SFRH/BD/115612/2016</funding_grant_id><pubmed_authors>Johnson RS</pubmed_authors><pubmed_authors>Zandhuis ND</pubmed_authors><pubmed_authors>Cunha PP</pubmed_authors><pubmed_authors>Jorgensen C</pubmed_authors><pubmed_authors>Wolkers MC</pubmed_authors><pubmed_authors>Sanchez-Lopez E</pubmed_authors><pubmed_authors>Foskolou IP</pubmed_authors><pubmed_authors>Nathanael D</pubmed_authors><pubmed_authors>Nicolet BP</pubmed_authors><pubmed_authors>Guislain A</pubmed_authors><pubmed_authors>Palazon A</pubmed_authors><pubmed_authors>Kostidis S</pubmed_authors><pubmed_authors>Giera M</pubmed_authors><pubmed_authors>Tyrakis PA</pubmed_authors><pubmed_authors>Barbieri L</pubmed_authors><pubmed_authors>Bargiela D</pubmed_authors><pubmed_authors>Minogue EA</pubmed_authors></additional><is_claimable>false</is_claimable><name>The two enantiomers of 2-hydroxyglutarate differentially regulate cytotoxic T cell function.</name><description>2-Hydroxyglutarate (2HG) is a byproduct of the tricarboxylic acid (TCA) cycle and is readily detected in the tissues of healthy individuals. 2HG is found in two enantiomeric forms: S-2HG and R-2HG. Here, we investigate the differential roles of these two enantiomers in cluster of differentiation (CD)8&lt;sup>+&lt;/sup> T cell biology, where we find they have highly divergent effects on proliferation, differentiation, and T cell function. We show here an analysis of structural determinants that likely underlie these differential effects on specific α-ketoglutarate (αKG)-dependent enzymes. Treatment of CD8&lt;sup>+&lt;/sup> T cells with exogenous S-2HG, but not R-2HG, increased CD8&lt;sup>+&lt;/sup> T cell fitness in vivo and enhanced anti-tumor activity. These data show that S-2HG and R-2HG should be considered as two distinct and important actors in the regulation of T cell function.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Sep</publication><modification>2026-04-08T18:33:16.129Z</modification><creation>2026-04-08T09:51:48.482Z</creation></dates><accession>S-EPMC7618115</accession><cross_references><pubmed>37632752</pubmed><doi>10.1016/j.celrep.2023.113013</doi></cross_references></HashMap>